Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saline vs Heparin for BioFlo Port Patency
NCT02923830Phase 4Terminated
- Sponsor
- TriHealth
- Start
- Apr 2016
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in catheter obstruction, sponsored by TriHealth. Started Apr 2016; status: terminated.
02
Drugs
heparin
03
Conditions
catheter obstruction
Beyond the preview
Go deeper on NCT02923830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02923830.